Vaccines & Disease · Shingles

Shingles Disease & Vaccine Information

Below are brief introductions to shingles disease and the shingles vaccine with links to more information. Scroll down for a list of QUICK FACTS that provide a summary overview of key facts for the disease and the vaccine.

The Disease

Shingles: The Disease

Herpes zoster, also known as shingles, is an inflammation of nerves and the surrounding area of skin caused by varicella zoster (chickenpox) virus infection.1 Shingles usually occurs when the dormant varicella zoster virus is reactivated in an adult who has recovered from chickenpox as a child.2 Shingles most commonly occurs in individuals over 50 years of age.3

Today, after chickenpox vaccine has been widely used by children since 1995 and has interrupted natural circulation of the varicella zoster virus in the U.S. population,4 experts believe that half of Americans reaching 85 years of age will experience shingles at some point in their lifetime.5

The Vaccine

Shingles Vaccine

There are two shingles vaccines licensed for use in the U.S.: Zostavax live attenuated vaccine by Merck6 and SHINGRIX, a genetically engineered and adjuvanted recombinant vaccine by GlaxoSmithKline Biologicals.7 Zostavax was discontinued in the U.S. in November 2020.8

Zostavax live attenuated shingles vaccine, licensed in 2006, is a much more potent version of Varivax chickenpox vaccine containing 19,500 plaque-forming units of Oka/Merck varicella zoster virus versus 1,350 plaque-forming units in the chickenpox vaccine.9 According to the CDC, Zostavax vaccine reduced shingles by about half (51%) in adults 60 years and older.10

SHINGRIX adjuvanted recombinant vaccine, licensed in 2017, is a two-dose series vaccine administered intramuscularly (injected into muscle) and is a genetically engineered vaccine.11 SHINGRIX is reported to be over 90 percent effective,12 but no test is available to determine immunity to shingles and long-term vaccine effectiveness is unknown.13

Quick Facts

Shingles at a glance

Shingles Quick Facts

  1. Herpes zoster (shingles) is a viral infection caused by the varicella zoster (chickenpox) virus.14 Individuals suffering with shingles cannot transmit shingles to others. However, someone who has never had chickenpox or the chickenpox vaccine can get chickenpox from a person with shingles. This is believed to be from direct contact with the shingles lesions.15
  2. Symptoms of shingles include pain, itching or tingling of areas of the skin, usually on the trunk of the body, along with fever, headache, chills and an upset stomach.16

Shingles Vaccine Quick Facts

  1. There are two vaccines licensed in the U.S.: Zostavax, a live virus vaccine, licensed in 2006 and manufactured by Merck,17 and SHINGRIX, a genetically engineered,18 recombinant, adjuvanted vaccine, licensed in 2017 and manufactured by GlaxoSmithKline Biologicals.19 Zostavax was discontinued in the U.S. in November 2020.20
  2. Using the MedAlerts search engine, as of January 2, 2026, there have been 134,663 reports of shingles vaccine reactions, hospitalizations, injuries and deaths following shingles vaccinations made to the federal Vaccine Adverse Event Reporting System (VAERS), including 585 related deaths, 6,013 hospitalizations, and 3,078 related disabilities.

IMPORTANT NOTE: NVIC encourages you to become fully informed about Shingles and the Shingles vaccine by reading all sections in the Table of Contents, which contain many links and resources such as the manufacturer product information inserts, and to speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child. This information is for educational purposes only and is not intended as medical advice.

References
  1. 1Mayo Clinic. Shingles. Aug. 20, 2022.
  2. 2National Institute of Neurological Disorders and Stroke (NINDS). What is Shingles? July 25, 2022.
  3. 3Nichols H. What is Shingles? Medical News Today. Sept. 21, 2021.
  4. 4Goldman GS, King PG. Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data. Vaccine. Mar. 25, 2013; 31(13): 1680–1694.
  5. 5US Centers for Disease Control and Prevention. CDC Recommends Shingles Vaccine. May 15, 2008.
  6. 6Merck & Co. Zostavax. U.S. Food and Drug Administration. Dec. 26, 2019.
  7. 7GlaxoSmithKline Biologicals. Package Insert – SHINGRIX. U.S. Food and Drug Administration. Aug. 2, 2021.
  8. 8US Centers for Disease Control and Prevention. What Everyone Should Know About Zostavax. Oct. 5, 2020.
  9. 9Fisher BL. The Emerging Risks of Live Virus & Virus Vectored Vaccines. National Vaccine Information Center. Nov. 2014.
  10. 10US Centers for Disease Control and Prevention. What Everyone Should Know about Zostavax. Oct. 5, 2020.
  11. 11GlaxoSmithKline Biologicals. Package Insert – SHINGRIX. U.S. Food and Drug Administration. Aug. 2, 2021.
  12. 12US Centers for Disease Control and Prevention. What Everyone Should Know about the Shingles Vaccine (Shingrix). May 24, 2022.
  13. 13Dooling KL, Guo A, Patel M, et al. Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines. MMWR. Jan. 26, 2018; 67(3):103–108.
  14. 14US Centers for Disease Control and Prevention. Clinical Overview. Oct. 5, 2020.
  15. 15US Centers for Disease Control and Prevention. Transmission.
  16. 16US Centers for Disease Control and Prevention. Signs and Symptoms.
  17. 17Merck & Co. Zostavax. U.S. Food and Drug Administration. Dec. 26, 2019.
  18. 18National Institute of Allergy and Infectious Diseases (NIAID). Vaccine Types. July 1, 2019.
  19. 19GlaxoSmithKline Biologicals. Package Insert – SHINGRIX. U.S. Food and Drug Administration. Aug. 2, 2021.
  20. 20US Centers for Disease Control and Prevention. What Everyone Should Know About Zostavax. Oct. 5, 2020.
Select disease / vaccine